LeMaitre Vascular acquires Admedus biologic patch business for up to $24.6M

LeMaitre Vascular has acquired Admedus' CardioCel and VascuCel biologic patch business for up to $24.6 million. Admedus will continue manufacturing for up to three years while LeMaitre sets up its own production.

“This transaction is a transformational milestone for Admedus, realizing the value from its CardioCel and VascuCel products.”massdevice.com

• 1 source
• massdevice.comAdmedus deals biologic patch business to LeMaitre Vascular for $24m - MassDeviceBrad PerrielloOct 15, 2019

Summarized from public sources; check the original articles before acting on it.